140 related articles for article (PubMed ID: 21223952)
1. Impact of CYP3A4*1G polymorphism on metabolism of fentanyl in Chinese patients undergoing lower abdominal surgery.
Yuan R; Zhang X; Deng Q; Wu Y; Xiang G
Clin Chim Acta; 2011 Apr; 412(9-10):755-60. PubMed ID: 21223952
[TBL] [Abstract][Full Text] [Related]
2. CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients.
Zhang W; Chang YZ; Kan QC; Zhang LR; Li ZS; Lu H; Wang ZY; Chu QJ; Zhang J
Eur J Clin Pharmacol; 2010 Jan; 66(1):61-6. PubMed ID: 19784640
[TBL] [Abstract][Full Text] [Related]
3. CYP3A4 * 1G Genetic Polymorphism Influences Metabolism of Fentanyl in Human Liver Microsomes in Chinese Patients.
Yuan JJ; Hou JK; Zhang W; Chang YZ; Li ZS; Wang ZY; Du YY; Ma XJ; Zhang LR; Kan QC; Candiotti KA
Pharmacology; 2015; 96(1-2):55-60. PubMed ID: 26088794
[TBL] [Abstract][Full Text] [Related]
4. Influence of CYP3A5*3 polymorphism and interaction between CYP3A5*3 and CYP3A4*1G polymorphisms on post-operative fentanyl analgesia in Chinese patients undergoing gynaecological surgery.
Zhang W; Yuan JJ; Kan QC; Zhang LR; Chang YZ; Wang ZY; Li ZS
Eur J Anaesthesiol; 2011 Apr; 28(4):245-50. PubMed ID: 21513075
[TBL] [Abstract][Full Text] [Related]
5. Effect of CYP3A4*1G on the fentanyl consumption for intravenous patient-controlled analgesia after total abdominal hysterectomy in Chinese Han population.
Dong ZL; Li H; Chen QX; Hu Y; Wu SJ; Tang LY; Gong WY; Xie GH; Fang XM
J Clin Pharm Ther; 2012 Apr; 37(2):153-6. PubMed ID: 21535061
[TBL] [Abstract][Full Text] [Related]
6. Impact of CYP3A4*1G Polymorphism on Fentanyl Analgesia Assessed by Analgesia Nociception Index in Chinese Patients Undergoing Hysteroscopy.
Yan Q; Su Y; Gao L; Ding N; Zhang HY; E W; Wang Y; Feng Y; An HY
Chin Med J (Engl); 2018 Nov; 131(22):2693-2698. PubMed ID: 30381583
[TBL] [Abstract][Full Text] [Related]
7. Association between MDR
Zhang J; Zhang L; Zhao X; Shen S; Luo X; Zhang Y
Gene; 2018 Jun; 661():78-84. PubMed ID: 29601950
[TBL] [Abstract][Full Text] [Related]
8. Patients with CYP3A4*1G genetic polymorphism consumed significantly lower amount of sufentanil in general anesthesia during lung resection.
Zhang H; Chen M; Wang X; Yu S
Medicine (Baltimore); 2017 Jan; 96(4):e6013. PubMed ID: 28121959
[TBL] [Abstract][Full Text] [Related]
9. Effect of Pregnane X Receptor
Yuan JJ; Ma XJ; Li ZS; Chang YZ; Zhang W; Kan QC; Hou JK; Zhang LR
BMC Med Genet; 2016 Nov; 17(1):87. PubMed ID: 27876007
[TBL] [Abstract][Full Text] [Related]
10. Significance of CYP3A4∗1G and OPRM1 A118G Polymorphisms in Postoperative Sufentanil Analgesia in Women of Different Ethnicities.
Zhang C; Zheng Q; Pan F; Wang T; Zhao Y; Xiao Z; Huang Z
Comput Math Methods Med; 2022; 2022():9833591. PubMed ID: 35799642
[TBL] [Abstract][Full Text] [Related]
11. CYP3A4 gene polymorphism is correlated with individual consumption of sufentanil.
Lv J; Liu F; Feng N; Sun X; Tang J; Xie L; Wang Y
Acta Anaesthesiol Scand; 2018 Nov; 62(10):1367-1373. PubMed ID: 29926893
[TBL] [Abstract][Full Text] [Related]
12. Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients.
Kim KM; Kim HS; Lim SH; Cheong SH; Choi EJ; Kang H; Choi HR; Jeon JW; Yon JH; Oh M; Shin JG
Int J Clin Pharmacol Ther; 2013 May; 51(5):383-92. PubMed ID: 23557865
[TBL] [Abstract][Full Text] [Related]
13. The effect of CYP3A4*1G allele on the pharmacokinetics of atorvastatin in Chinese Han patients with coronary heart disease.
He BX; Shi L; Qiu J; Zeng XH; Zhao SJ
J Clin Pharmacol; 2014 Apr; 54(4):462-7. PubMed ID: 24214373
[TBL] [Abstract][Full Text] [Related]
14. Effect of CYP3A4*18B polymorphisms and interactions with OPRM1 A118G on postoperative fentanyl requirements in patients undergoing radical gastrectomy.
Liao Q; Chen DJ; Zhang F; Li L; Hu R; Tang YZ; Ou-Yang W; Huang D
Mol Med Rep; 2013 Mar; 7(3):901-8. PubMed ID: 23313934
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 3A4 genetic polymorphisms and post-operative fentanyl requirements.
Tan PC; Hassan SK; Mohamad NA; Gan SH
J Clin Pharm Ther; 2012 Feb; 37(1):100-4. PubMed ID: 21128989
[TBL] [Abstract][Full Text] [Related]
16. Effect of CYP3A4 and CYP3A5 Genetic Polymorphisms on the Pharmacokinetics of Sirolimus in Healthy Chinese Volunteers.
Zhang J; Dai Y; Liu Z; Zhang M; Li C; Chen D; Song H
Ther Drug Monit; 2017 Aug; 39(4):406-411. PubMed ID: 28700521
[TBL] [Abstract][Full Text] [Related]
17. Significant impacts of CYP3A4*1G and CYP3A5*3 genetic polymorphisms on the pharmacokinetics of diltiazem and its main metabolites in Chinese adult kidney transplant patients.
Zhou LY; Zuo XC; Chen K; Wang JL; Chen QJ; Zhou YN; Yuan H; Ma Y; Zhu LJ; Peng YX; Ming YZ
J Clin Pharm Ther; 2016 Jun; 41(3):341-7. PubMed ID: 27149910
[TBL] [Abstract][Full Text] [Related]
18. Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese.
Chan SW; Xiao Y; Hu M; Yin OQ; Chu TT; Fok BS; Lee VH; Tomlinson B
J Clin Pharm Ther; 2016 Oct; 41(5):552-8. PubMed ID: 27511886
[TBL] [Abstract][Full Text] [Related]
19. A functional polymorphism in the CYP3A4 gene is associated with increased risk of coronary heart disease in the Chinese Han population.
He BX; Shi L; Qiu J; Tao L; Li R; Yang L; Zhao SJ
Basic Clin Pharmacol Toxicol; 2011 Mar; 108(3):208-13. PubMed ID: 21199372
[TBL] [Abstract][Full Text] [Related]
20. Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
Yun W; Zhang F; Hu C; Luo X; Xue P; Wang J; Ge Y; Meng H; Guo Y
Epilepsy Res; 2013 Dec; 107(3):231-7. PubMed ID: 24125961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
